Page last updated: 2024-08-18

pyrazolanthrone and Severe Dengue

pyrazolanthrone has been researched along with Severe Dengue in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheunsuchon, B; Chuncharunee, A; Limjindaporn, T; Noisakran, S; Sreekanth, GP; Yenchitsomanus, PT	1

Other Studies

1 other study(ies) available for pyrazolanthrone and Severe Dengue

Article	Year
JNK1/2 inhibitor reduces dengue virus-induced liver injury. Antiviral research, 2017, Volume: 141 Topics: Animals; Anthracenes; Apoptosis; Caspases; Dengue Virus; Disease Models, Animal; Leukopenia; Liver; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Severe Dengue; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Viral Load	2017

Article

Year

JNK1/2 inhibitor reduces dengue virus-induced liver injury.

Antiviral research, 2017, Volume: 141

Topics: Animals; Anthracenes; Apoptosis; Caspases; Dengue Virus; Disease Models, Animal; Leukopenia; Liver; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Severe Dengue; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Viral Load

2017